Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability

Journal of Cardiovascular Surgery

Volumn 40, Issue 3, 1999, Pages 363-372

  Landoni, C ^b   Lucignani, G ^b   Paolini, G ^b   Zuccari, M ^b   Galli, L ^b   Di Credico, G ^b   Rossetti, C ^b   Pelenghi, S ^b   Gilardi, M C ^b   Fazio, F ^a   Grossi, A ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Coronary artery bypass; Tomography emission computed; Ventricular dysfunction, left

Indexed keywords

FLUORODEOXYGLUCOSE F 18; INOTROPIC AGENT;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; CORONARY DISEASE; DECISION MAKING; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL STUNNING; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033025003     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R, Francis X. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1193-8.
2. van den Berg EK Jr, Popma JJ, Dehmer GJ, Snow FR, Lewis SA, Vetrovec GW et al. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990;81:1210-6.
3. Rees G, Bristow JD, Kremkau EL, Green GS, Herr RH, Griswold HE et al. Infuence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284:1116-20.
4. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease with and without previuos myocardial infarction. Circulation 1973;67:276-86.
5. Kennedy JW, Kaiser GC, Fisher LD, Fritz JK, Myers W, Mudd JG et al. Clinical and angiography predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation 1981;63:793-802.
6. Nwasokwa ON, Koss JH, Friedman, Grunwald AM, Bodenheimer MM. Bypass surgery for chronic stable angina: predictors of survival benefit and strategy for patient selection. Annals of Internal Medicine 1991;114:1035-49.
7. Zubiate P, Kay IH, Mendez AM. Myocardial revascularization for the patient with drastic impairment of function of left ventricle. J Thorac Cardiovasc Surg 1977;73:84-6.
8. Hellman C, Schmidt DH, Kanath ML, Blau F, Johnson WD. Bypass graft surgery in severe left ventricular dysfunction. Circulation 1980;62 (Suppl I):92-6.
9. Hochberg MS, Parsonnet V, Gielchinsky I, Hussani SM. Coronary artery bypass grafting in patients with ejection fraction below forty percent. J Thorac Cardiovasc Surg 1983;86:519-25.
10. Kron IL, Flanagan TL, Blackbourne LH, Schroeder RA, Nolan SP. Myocardial revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Ann Surg 1989;210:348-52.
11. Louie HW, Laks H, Milgalter K, Drinkwater DC Jr, Hamilton MA. Brunken RC et al. Ischemic cardiomyopathy: criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84 (Suppl III):III290-III295.
12. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R. Mandelkern J et al. Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73: 951-63.
13. 201Tl SPECT. Radiology 1989;172: 65-73.
14. Tamaki N, Yonekura Y, Yamashita K, Saji H, Magata Y, Senda M et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary bypass grafting. Am J Cardiol 1989;64:860-5.
15. Tamaki N, Ohtani H, Yamashita K, Magata Y, Yonekura Y, Nohara R et al. Metabolic activity in the areas of new fill-in after thallium -201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991;32:673-8.
16. 18F]FDG/PET in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-82.
17. Marshall RC, Tillisch JH, Phelps ME, Fluang SC, Carson R, Henze E et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 1983;67:766-78.
18. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M et al. Reversibility of wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
19. Carrel T, Jenni R, Haubold-Reuter S, Von Schulthess G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992;6:479-84.
20. Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Harkonen R, Ahonen A et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33:1255-62.
21. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
22. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94
23. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
24. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid and reverse ischemic and reperfusion damage. J Thorac Cardivasc Surg 1987;93:127-39.
25. Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Cardiac Surg 1989;4:216-38.
26. Bounous FP, Mark DB, Pollock BG, Hlatky MA, Harrell FE Jr, Lee KL et al. Surgical survival benefits for coronary disease in patients with left ventricular dysfunction. Circulation 1988;78 (Suppl I):I151 -1157.
27. Besozzi MC, Brown MD, Hubner KF, Smith GT, Bound HW, Goodman MM et al. Retrospective post-therapy evaluation of cardiac function in 208 coronary artery disease patients evaluated by positron emission tomography (abstr). J Nucl Med 1992;33:885.
28. Depre C, Melin J, Vanoverschelde J, Borgers M, Wijns W. Assessment of myocardial viability after bypass surgery by preoperative PFT flow-metabolism measuremens and ultrastructural analysis of myocardial byopsies. Circulation 1993;88:I-199.
29. Hass F, Habnel C, Sebering F, Messner H, Schwaiger M. Effect of preoperative PET viability on peri-and postoperative risk (abstr). J Am Coll Cardiol 1996;27(Suppl A):300A.
30. Hung J, Kelly DT, Baird DK, Hendel PN, Leckie BD, Grant AF et al. Aorta-coronary bypass grafting in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 1980;79:718-23.
31. Alderman EL, Fischer LD, Litwin P, Kaiser GC, Meyers NO, Maynard C. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
32. Shearn D, Brent B. Coronary artery bypass surgery in patients with left ventricle dysfunction. Am J Med 1986;80:405-11.
33. Cohn PF, Gorlin R, Cohn LH, Collins JJ Jr. Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol 1974;34:136.
34. Cales JG, Del Campo C, Anemed SN, Carpus R, Goidbach MM. Improved long term survival following myocardial revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 1981;81:846-50.
35. Pibbott JB, Kouchoukos NT, Oberrnan A, Cutter GR. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-45.